Table 2.
Demographics, characteristics, treatment details, and clinical outcomes of acute ischemic stroke patients in the COVID-19 period in comparison to the pre-COVID-19 period.
| COVID-19 | pre-COVID-19 | t/Z/χ2 | P value | |
|---|---|---|---|---|
| (n = 56) | (n = 113) | |||
| Female, n (%) | 23 (41.1) | 46 (40.7) | 0.002 | 0.964 |
| Age (years), mean ± SD | 71 ± 13 | 68 ± 14 | 1.307 | 0.193 |
| Urban resident, n (%) | 21 (37.5) | 45 (39.8) | 0.085 | 0.771 |
| LKN to hospital arrival(min), IQR | 242.5 (181,599) | 359 (185,1377) | 1.518 | 0.129 |
| Arrival mode: EMS, n (%) | 21 (37.5) | 27 (23.9) | 3.409 | 0.065 |
| Length of stay (d), IQR | 10.5 (5.75,15) | 11 (6,13) | 0.884 | 0.377 |
| Denial of medical services, n (%) | 14 (25.0) | 28 (24.8) | 0.001 | 0.975 |
| NIHSS at presentation, mean ± SD | 9 ± 8 | 9 ± 8 | 0.148 | 0.882 |
| Intravenous thrombolysis, n (%) | 11 (19.6) | 30 (26.5) | 0.972 | 0.324 |
| Door-to-needle (min), mean ± SD | 52.45 ± 26.14 | 43.13 ± 34.27 | 0.822 | 0.416 |
| Endovascular thrombectomy, n (%) | 11 (19.6) | 16 (14.2) | 0.839 | 0.360 |
| Door-to-puncture(min), mean ± SD | 109.18 ± 71.39 | 270.50 ± 161.51 | 3.526 | 0.002 |
| mRS at 90 days ≥ 3, n (%) | 10 (17.9) | 26 (23.0) | 0.593 | 0.441 |
| Deaths, n (%) | 2 (3.6) | 4 (3.5) | 0.000 | 1.000 |
COVID-19, coronavirus disease 2019; LKN, last known normal; EMS, emergency medical services; SD, standard deviation; IQR, interquartile range; Denial of medical services indicates the patient had a refusal of medical care recommended by medical personnel; NIHSS, National Institutes of Health Stroke Scale; mRS, modified Rankin Scale.